Current Headlines

  1. Immunomedics Gets EU Orphan Status For Pancreatic Cancer ADC
    10/23/2014

    Clinical stage biopharmaceutical company Immunomedics announced that it has received Orphan Drug status for isactuzumab govitecan (IMMU-132) for the treatment of pancreatic cancer.

  2. FDA Accepts Merck’s, Sanofi’s BLA For Pediatric Hexavalent Vaccine
    10/23/2014

    Merck and Sanofi are a step closer to approval of their pediatric hexavalent vaccine, (DTaP5-IPV-Hib-HepB1), as the Food and Drug Administration (FDA) has accepted their Biologics License Application (BLA). The two companies announced the application acceptance in a press release, stating that the pediatric combination vaccine helps protect against six diseases.

  3. UCSF, CDRD Partner To Address ‘Valley of Death’ In Drug Development
    10/23/2014

    The University of California San Francisco (UCSF) and The Center for Drug Research and Development (CDRD) have partnered to address the ‘Valley of Death’, the phase between therapy discovery and commercialization. UCSF announced the partnership in a press release, stating that the collaboration seeks to take the University’s laboratory inventions into the marketing stage.

  4. Leading Researchers Join Biogen Idec To Advance Drug Discovery For Neurodegenerative Diseases
    10/23/2014

    Biogen Idec recently announced that two leading neuroscientists have joined the company to advance its research in neurodegenerative diseases. Christopher Henderson, Ph.D., joins as vice president, Neurology. Richard Ransohoff, M.D., joins as senior research fellow, Neuroimmunology.

  5. Karolinska Institutet Links With Moderna In mRNA Therapeutics
    10/22/2014

    Moderna Therapeutics, Karolinska Institutet (KI), and Karolinska University Hospital (KUH) have joined forces to discover and develop drugs using messenger RNA (mRNA) Therapeutics technology.

  6. AstraZeneca Bolsters Partnership With U Of Cambridge
    10/22/2014

    AstraZeneca and its global biologics R&D arm MedImmune announced four new collaborations with the University of Cambridge, all launched in an attempt to strengthen AZ’s existing partnership with the University as the company sets out to expand its research infrastructure in Cambridge.

  7. New Initiative Launched To Promote Biotech Education
    10/22/2014

    The Biogen Idec Foundation is offering up a $1.5 million grant in an effort to boost the biotechnology industry’s visibility.

  8. University Of Pennsylvania’s T-Cell Therapy Shows Promising Results
    10/22/2014

    The University of Pennsylvania has announced promising results of its novel chimeric antigen receptor (CAR) therapy for cancer.

  9. Lilly To Streamline Manufacturing Operations In 2015
    10/21/2014

    Eli Lilly announced its plans to close one of its three manufacturing plants in Puerto Rico by the end of next year.

  10. Janssen And Aduro Ink New Deal In Lung Cancer Immunotherapy
    10/21/2014

    Janssen Biotech and Aduro BioTech announced their second agreement to develop treatments for lung cancer using Aduro’s LADD immunotherapy platform.

Newsletter Signup
Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.